Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases
Publisher： Bentham Science Publishers
E-ISSN： 2212-2710|3|3|177-187
ISSN： 1872-213X
Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.3, Iss.3, 2009-11, pp. : 177-187
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
